Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-058707
Filing Date
2015-08-11
Accepted
2015-08-11 16:02:14
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12133_110q.htm 10-Q 752354
2 EX-31.1 a15-12133_1ex31d1.htm EX-31.1 13269
3 EX-31.2 a15-12133_1ex31d2.htm EX-31.2 13268
4 EX-32.1 a15-12133_1ex32d1.htm EX-32.1 7085
5 EX-32.2 a15-12133_1ex32d2.htm EX-32.2 7098
  Complete submission text file 0001104659-15-058707.txt   4106904

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT trvn-20150630.xml EX-101.INS 868327
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trvn-20150630.xsd EX-101.SCH 30278
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trvn-20150630_cal.xml EX-101.CAL 34337
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trvn-20150630_def.xml EX-101.DEF 145742
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT trvn-20150630_lab.xml EX-101.LAB 346425
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trvn-20150630_pre.xml EX-101.PRE 254732
Mailing Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406
Business Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406 610-354-8840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 151043893
SIC: 2834 Pharmaceutical Preparations